Sarcopenia quietly undermines independence in older adults long before a diagnosis is made, and understanding precisely how exercise counteracts it at the molecular level could reshape both prevention strategies and future drug targets. A comprehensive review in Biochemical Genetics synthesizes the epigenetic architecture connecting aging muscle decline to exercise-induced recovery, offering one of the more mechanistically detailed accounts available in the literature.
The review centers on how aging progressively distorts the epigenetic landscape of skeletal muscle — shifting histone acetylation and methylation patterns in ways that promote anabolic resistance, chronic low-grade inflammation, and impaired satellite cell regeneration. Exercise, the analysis argues, is not merely a mechanical stimulus but a genuine epigenetic reprogramming agent. Resistance and endurance training modulate histone acetyltransferase and deacetylase activity, restore permissive chromatin states at genes governing muscle protein synthesis, and recalibrate microRNA and long non-coding RNA profiles that govern muscle plasticity. Notably, the review highlights histone lactylation — a relatively novel epigenetic mark derived from lactate produced during exercise — as an emerging mechanistic link between metabolic activity and gene expression in muscle tissue, a connection that has received scant attention in mainstream longevity discourse.
This synthesis matters for several reasons beyond the science itself. First, it bridges animal-model mechanistic data with emerging human clinical trial evidence, an honest acknowledgment that human epigenetic data in aging muscle remain sparse. Second, the dose-dependent relationship between training variables and epigenetic outcomes suggests that exercise prescription for older adults may eventually be calibrated at a molecular resolution. Third, the interplay between histone modifiers and non-coding RNAs opens a potential therapeutic window: small-molecule HDAC inhibitors and miRNA mimics could theoretically replicate or amplify exercise's epigenetic effects in frail individuals unable to train adequately. As a review, this work is inherently dependent on the quality of primary studies it synthesizes, and causal directionality in human cohorts remains difficult to establish. Still, it represents a useful consolidation of a rapidly maturing field, incremental rather than paradigm-shifting, but practically informative for researchers and clinicians designing exercise interventions for aging populations.
